Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activating transcription factor 4 pseudogene 4 (ATF4P4) is a human genomic locus structurally related to the protein-coding ATF4 gene, but does not encode a functional protein. It is classified as a pseudogene—an evolutionary remnant of the active ATF4 gene—with no evidence for active transcript or peptide product[2][6]. ATF4P4 is sometimes also referenced as ATF4B. Unlike ATF4, which is a bZIP transcription factor involved in stress response, metabolism, and development[1][3][5], ATF4P4 itself is not considered a functional target and has no documented involvement in molecular signaling, disease processes, or pharmaceutical intervention[2][6]. Critical Clarification: - ATF4P4 must not be confused with ATF4, which is an important transcription factor with both biological functions and disease relevance. ATF4P4 is a pseudogene derivative, lacking the protein-coding capacity and active role attributed to ATF4[1][2][6]. - If the intention was to query the protein-coding gene ATF4, refer to “Activating transcription factor 4 (ATF4),” which is a well-characterized transcription factor in cellular stress response and disease biology[1][3][5]. - The information on ATF4 is not transferable to ATF4P4, as the latter does not contribute directly to cellular or disease pathways. Summary of Correct/Incorrect Target Status: - ATF4P4 is a structurally homologous DNA sequence but is not a protein, receptor, or functional target. - No aliases, disease roles, drugs, or pathways pertain to ATF4P4. - No meaningful information exists for biological function or drug targeting of ATF4P4; any such associations are with ATF4, not the pseudogene[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activating transcription factor 4 pseudogene 4 (ATF4P4).